Playtech H1 2026 slides: 77% EBITDA surge, Americas drive growth

Playtech reported H1 2026 adjusted EBITDA of €163 million, up 77% year over year, on 10% revenue growth to €425.1 million; free cash flow surged to €101 million from €6.6 million. Growth was led by the Americas, with U.S. and Canada revenue up 161% underlying and the U.S. business reaching profitability ahead of plan, while B2B EBITDA margin expanded to 32.4% from 21.1%. Management maintained FY2026 adjusted EBITDA guidance above €270 million but warned that Hard Rock Digital income will normalize in H2; shares were largely unchanged, up 0.2%.

Analysis

PTEC’s valuation should increasingly be framed as a sum-of-the-parts rather than a conventional gaming-software multiple: recurring B2B earnings, a fast-scaling regulated-Americas platform, and sizable minority holdings whose carrying values may lag realizable value. The key earnings-quality issue is that a meaningful share of cash conversion depends on associate distributions and investment income, not solely owned operating EBITDA. That makes the next 1-3 months dependent on whether management can quantify sustainable run-rate operating cash flow excluding unusually favorable partner distributions.

The muted equity response is constructive if investors expected a guidance raise, but it also signals skepticism around the second-half deceleration. The asymmetry improves if full-year results show that U.S. profitability persists while Europe’s weakness remains contained: that would support a re-rating toward higher-quality vertical-market software peers, albeit still discounted for gambling regulation and minority-investment opacity. Conversely, weaker distributions, partner valuation marks, or reinvestment that pushes development spend above plan could expose the difference between headline FCF and owner earnings.

Competitive implications favor scaled live-casino suppliers with regulated-market infrastructure, but PTEC’s U.S. customer concentration is a hidden risk: operator partners can internalize technology or use supplier bargaining power once state markets mature. Evolution (EVO.ST) is the cleaner live-dealer competitive read-through; sustained PTEC share gains in North America would challenge the view that Evolution’s scale is unassailable. The market may also be underestimating regulatory optionality in Latin America, where formalization can expand the addressable market but may simultaneously raise tax and compliance costs.

Near-term catalysts are updated medium-term targets, disclosure on the implied value and liquidity of strategic stakes, and evidence that H2 margins remain above pre-transformation levels. Falsify a constructive view if FY EBITDA merely meets the low end of guidance despite the strong first half, if normalized FCF falls below the stated medium-term range after stripping associate dividends, or if net debt rises without an accretive acquisition rationale.

Key Decisions for Investors

• Watch-list PTEC for a post-results entry rather than chase strength: initiate only if FY guidance is maintained or raised and normalized operating FCF supports at least €70-100m excluding exceptional associate distributions. Target a 12-18 month re-rating on improved earnings quality; exit on a material FY EBITDA guide-down or evidence of deteriorating partner cash distributions.
• Construct a 3-6 month relative-value basket: long PTEC / short EVO.ST in equal beta-adjusted amounts if U.S. revenue growth and profitability remain demonstrably above sector growth. The thesis is relative North American share capture and SOTP upside; stop out if PTEC’s U.S. growth decelerates sharply while Evolution sustains superior margin expansion.
• Do not use ADBE, ORCL, APP, or SMCI as read-through trades from this item; they are unrelated tickers in the supplied dataset. Treat their earnings as broader risk-sentiment inputs only, not a fundamental catalyst for PTEC.
• Set an alert around the FY target review: an explicit increase in medium-term EBITDA/FCF targets or a capital-return framework tied to surplus cash would be a buy catalyst; a decision to deploy capital into opaque minority investments instead of returning it should warrant a valuation discount.